Early-onset colorectal cancer in pediatric patient

Sarp Tunalı1, Kamil Erözkan1, Yiğit Türk1

  • 1Department of General Surgery, Ege University Hospital, İzmir, Türkiye.

Turkish Journal of Surgery
|February 24, 2026
PubMed

Insights

Pediatric colorectal cancer is rare but rising. This case highlights a 17-year-old

Area of Science:

  • Oncology
  • Pediatric Surgery
  • Gastroenterology

Background:

  • Early-onset colorectal cancer (CRC) incidence is increasing, particularly in younger populations.
  • Colorectal cancer in pediatric patients is rare, often presenting late with obstructive symptoms.
  • This case report focuses on a 17-year-old female with advanced-stage pediatric CRC.

Purpose of the Study:

  • To describe the clinical presentation and management of a rare case of pediatric colorectal cancer.
  • To emphasize the importance of considering pediatric CRC in the differential diagnosis of persistent gastrointestinal symptoms.
  • To highlight the role of genetic counseling in managing pediatric CRC.

Main Methods:

  • Case report of a 17-year-old female presenting with obstructive symptoms.
  • Diagnostic workup including computed tomography (CT) scan.
  • Surgical intervention: laparotomy with extended left hemicolectomy and Mikulicz colostomy.
  • Histopathological analysis and genetic mutation screening (BRAF, KRAS, NRAS, mismatch repair proteins, ATM gene).

Main Results:

  • A 4 cm splenic flexure tumor with signs of obstruction and suspected metastatic mesenteric lymphadenopathy was identified.
  • Histopathology confirmed mucinous adenocarcinoma with extensive lymph node metastasis (17/42).
  • No common CRC mutations (BRAF, KRAS, NRAS) were detected; mismatch repair protein expression was intact. A variant of uncertain significance in the ATM gene was found.

Conclusions:

  • Pediatric-onset colorectal cancer should be considered in children with persistent gastrointestinal issues, as delays can lead to advanced disease.
  • Genetic counseling is crucial for management and understanding potential hereditary links.
  • Multidisciplinary collaboration among surgeons and oncologists is essential for optimal patient outcomes.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
375
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
329
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
286
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
359
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
1.3K